K173961 is an FDA 510(k) clearance for the Straumann BLX Implant System. This device is classified as a Implant, Endosseous, Root-form (Class II - Special Controls, product code DZE).
Submitted by Institut Straumann AG (Basel, CH). The FDA issued a Cleared decision on June 5, 2018, 159 days after receiving the submission on December 28, 2017.
This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3640.
| 510(k) Number | K173961 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | December 28, 2017 |
| Decision Date | June 05, 2018 |
| Days to Decision | 159 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
| Product Code | DZE — Implant, Endosseous, Root-form |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 872.3640 |